Generic Name
LinagliptinPacks Price
- In Pack
Tradjenta
Therapeutic Group
Blood Glucose Lowering Drugs, Excluding InsulinIndication Dosage
Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, used in the management of type 2 diabetes mellitus. As a selective and potent DPP-4 inhibitor, it enhances glycemic control by increasing endogenous incretin hormones, such as GLP-1 and GIP, which stimulate insulin release and reduce glucagon secretion. Linagliptin is characterized by its once-daily dosing regimen, a low potential for drug-drug interactions, and a favorable side effect profile. It is a valuable therapeutic option for individuals with type 2 diabetes who require adjunctive treatment to improve blood glucose control while minimizing the risk of hypoglycemia and other adverse effects.
Dosage:
- Adult: 5mg Once Daily.
Content
- Tab 5mg: Linagliptin 50mg
Pregnancy
Contraindicated in Pregnancy
Stability
- Dipeptidyl Peptidase-4 Inhibitor
Contra Indications
- Linagliptin is contraindicated in patients with a history of a hypersensitivity reaction to linagliptin or its components.
Precautions
- Linagliptin is contraindicated in patients with a history of a hypersensitivity reaction to linagliptin or its components.
Lactation
- Contraindicated or Not Recommended
Side Effects
- Cough
- Nasopharyngitis
- Pancreatitis Discontinue if Symptoms of Acute Pancreatitis
Available Brands
Author
Shahid Arif